Comments
Shares of Claris Lifesciences will remain in focus, as the company’s buyback window opens on Thursday. The company plans to buy back up to 92.5 lakh equity shares at a price of ₹250 a share from eligible shareholders, whose name appears on the company’s books on April 2. The buyback through the tender offer route gives an option to all shareholders, including the promoters, to receive the surplus cash. The buyback window closes on May 22.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.